Every new drug has challenges to overcome on its journey from discovery to market. With today's more specific targets and more challenging chemical spaces, drug delivery and development often requires an enabling technology. We provide a collaborative R&D approach, specializing in particle engineering, drug delivery, drug development and manufacturing expertise to the pharmaceutical industry. We want to partner with you on your challenging molecule and help bring it to market. How can we help?
| Website | http://www.bendbioscience.com |
| Revenue | $31.4 million |
| Employees | 66 (41 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Drug Discovery, Drug Delivery, Drug Development, Pharmaceutical, Biotechnology, Bioscience, Therapeutics, Biopharma, Collaborative Research, Medicinal Chemistry, Formulation Development, Pharmaceutical Research, Process Development, Contract Research, Clinical Trials, Analytical Testing, Regulatory Affairs, Precision Medicine |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck AH, Bristol Myers Squibb, Amgen, Gilead Sciences, Biogen, Pfizer, Lilly India +43 more (view full list) |
Looking for a particular Bend Bioscience employee's phone or email?
The Bend Bioscience annual revenue was $31.4 million in 2026.
Scott Rizzo is the Board Member - Audit committee member of Bend Bioscience.
41 people are employed at Bend Bioscience.
Bend Bioscience is based in Bend, Oregon.